For both health systems and investors, the most exciting signal is how AI amplifies advances in biotechnology.

Since the law’s passage, companies have halted at least 55 research programs and given up 26 medicines.

EMBL researchers have created a new AI tool that uses a “molecular laser tag” approach to identify cells capable of revealing the earliest origins of cancer. The human body depends on accurate genetic ...